Source:http://linkedlifedata.com/resource/pubmed/id/11168989
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. In patients with end-stage renal failure (ESRF), disturbances of Ca2+ metabolism are common. Besides hormonal changes, inhibition of cellular Ca2+-ATPase was postulated to contribute to uremic toxicity. We purified a potent inhibitor of the Ca2+-ATPase from the ultrafiltrate of patients with ESRF by multiple steps of high-performance liquid chromatography to homogeneity, and identified the isolated inhibitor by mass spectrometric methods as p-hydroxy-hippuric acid. The enzyme used for the Ca2+-ATPase assay system was isolated from red blood cells by cross-flow filtration. The activity of the Ca2+-ATPase was measured spectrophotometrically as the difference in hydrolysis of adenosine 5'-triphosphate (ATP) in the presence and absence of Ca2+ with different concentrations of ATP and p-hydroxyhippuric acid. The Ca2+-ATPase was found to be inhibited by p-hydroxy-hippuric acid at a concentration above 11.7 micromol/L. p-Hydroxyhippuric acid inhibited the erythrocyte Ca2+-ATPase by reducing Vmax and increasing the Km value. The EC50 (log mol/L; mean +/- SEM) for p-hydroxy-hippuric acid was calculated as 4.82 +/- 0.14. In conclusion, p-hydroxy-hippuric acid may play a role in disturbed Ca2+ metabolism in end-stage renal failure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0098-6577
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S84-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11168989-Calcium-Transporting ATPases,
pubmed-meshheading:11168989-Case-Control Studies,
pubmed-meshheading:11168989-Enzyme Inhibitors,
pubmed-meshheading:11168989-Erythrocyte Membrane,
pubmed-meshheading:11168989-Female,
pubmed-meshheading:11168989-Hemofiltration,
pubmed-meshheading:11168989-Hippurates,
pubmed-meshheading:11168989-Humans,
pubmed-meshheading:11168989-Kidney Failure, Chronic,
pubmed-meshheading:11168989-Male
|
pubmed:year |
2001
|
pubmed:articleTitle |
Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure.
|
pubmed:affiliation |
Medizinische Klinik I, Universitäst-Klinik Marienhospital, Ruhr-Universität Bochum, Herne, Germany.
|
pubmed:publicationType |
Journal Article,
In Vitro
|